Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
37 Results for "
CD70
" in MedChemExpress (MCE) Product Catalog:
Products (37)
37 Results for "CD70" in MCE Product Catalog:
1
Target:
Research Areas:
Cat. No.: HY-P99273
CAS No.: 1165740-62-4
Target:
Research Areas:
Cat. No.: HY-P99334
CAS No.: 1165741-01-4
Synonyms: Anti-Human CD70 Recombinant Antibody; SGN-75
Research Areas:
Cat. No.: HY-P990264
Target:
Research Areas:
Cat. No.: HY-174736
Target:
Research Areas:
Human CD70 mRNA encodes the human CD70 molecule (CD70) protein, a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. CD70 induces proliferation of costimulated T cells, enhances the generation of cytolytic T cells, and contributes to T cell activation. It is also reported to play a role in regulating B-cell activation, cytotoxic function of natural killer cells, and immunoglobulin sythesis.
Cat. No.: HY-P991645
Synonyms: MDX-1203 antibody; BMS-936561 antibody
Target:
Research Areas:
Cat. No.: HY-178257
CAS No.: 2901788-27-8
Target:
Research Areas:
Fmoc-Val-Lys-PAB-Exatecan is a derivative of Exatecan (DX-8951) (HY-13631). Fmoc-Val-Lys-PAB-Exatecan can be connected to monoclonal antibodies via linkers to form antibody-drug conjugate (ADC) molecules. Fmoc-Val-Lys-PAB-Exatecan is often combined with CD70 mAb to form ADC drugs for the study of tumors with high CD70 expression .
Cat. No.: HY-RS02264
Target:
Research Areas:
CD70 Human Pre-designed siRNA Set A contains three designed siRNAs for CD70 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS16751
Target:
Research Areas:
Cd70 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Cd70 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS23190
Target:
Research Areas:
Cd70 Rat Pre-designed siRNA Set A contains three designed siRNAs for Cd70 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-160649
CAS No.: 1599439-52-7
Research Areas:
MC-Gly-Gly-Phe-Gly-GABA-Exatecan is an agent linker conjugate for ADC, with an inhibitor for Topoisomerase Exatecan (HY-13631) with IC50 of 22 μM. MC-Gly-Gly-Phe-Gly-GABA-Exatecan targets various antibodies, exhibits cytotoxic and antitumor efficacy in vitro and in vivo .
Cat. No.: HY-P991809
Target:
Research Areas:
Cat. No.: HY-P991562
CAS No.: 2101467-47-2
Target:
Research Areas:
Cat. No.: HY-P991120
CAS No.: 3010940-29-8
Synonyms: PF-08046040; SGN-CD70
Target:
Research Areas:
Cat. No.: HY-P990261
Target:
Research Areas:
Cat. No.: HY-178271
CAS No.: 147597-66-8
Target:
Research Areas:
P-SCN-Bn-NOTA is a metal chelator and molecular imaging probe precursor that allows radiolabeling with Ga-68. P-SCN-Bn-NOTA can be conjugated to CD70-specific molecules B3, B6, ABDB3 and ABDB6 to form NOTA-labeled derivatives. P-SCN-Bn-NOTA is applicable for preclinical PET/CT imaging of CD70-expressing tumors in NCG mouse PDX models. P-SCN-Bn-NOTA can be used in studies related to CD70-positive tumors .
Cat. No.: HY-P704279
Purity: ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: CD70 antigen; CD70; CD27 ligand; CD27LG; TNFSF7; CD27L
Cat. No.: HY-P704364
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CD70 antigen; CD70; CD27 ligand; CD27LG; TNFSF7; CD27L
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
